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 INTRODUCTION 
 The first case of human monkeypox (MPX) was identified 
in 1970 in the Basankusu District of the Democratic Republic 
of the Congo (former Zaire) during the intensification phase 
of the smallpox eradication campaign. 1 In that same year, five 
additional MPX cases were reported in west Africa, four in 
Liberia and one in Sierra Leone. 2, 3 However, during the sub-
sequent 13 years, only 11 of the 155 MPX cases identified 
in Africa were reported from west Africa countries (Côte 
d’Ivoire, Liberia, Nigeria, Sierra Leone); 4 most cases occurred 
in the Democratic Republic of the Congo. 
 The natural cycle of MPX within its native range is poorly 
understood, as is the route of transmission to humans in the 
tropical forest setting. The only MPX virus isolated from a 
wild-caught mammal was obtained from a single moribund 
rope squirrel ( Funisciurus anerythrus ) collected during an 
outbreak investigation in Zaire. 5 Primary human (and non-
human primate) infections are hypothesized to result from 
contact with an infected sylvan animal, although this reservoir 
host species is currently unknown. 
 Most of the previous field investigations designed to identify 
the sylvatic reservoir of MPX virus were confined to relatively 
short-term outbreak responses and involved general broad 
spectrum collections of a wide variety of mammalian taxa. The 
taxa and animals examined were mostly composed of those 
species that can be purchased from local hunters and collec-
tors. Such taxonomically broad surveys yield large numbers of 
samples, but usually do not sufficiently sample any individual 
taxon given the likelihood of a low incidence of active infec-
tions in presumptive reservoir species. 6– 8 
 Human MPX has never been described in Ghana, although 
ecologic niche models predict limited regions of suitable ecol-
ogy may exist in this country, 9 and the purported source of the 
virus introduced into the United States in 2003 was rodents 
imported from Ghana. 10, 11 Fourty-seven confirmed and prob-
able human infections were reported during the outbreak 
in the United States and at least nine mammal species, rep-
resenting Old World and New World species, were newly 
recognized as being capable of hosting infections with mon-
keypox virus (MPXV). 11 Members of three genera of African 
rodent were implicated as the initial, inadvertent, source of 
importation of the virus into the United States, these being 
 Cricetomys ,  Graphiurus , and  Funisciurus (commonly known 
as giant pouched rat, African dormouse and rope squirrel, 
respectively). 11 Multiple individuals of each of these types of 
animal were captured in Ghana and sent to the United States 
for sale as pets. The animals arrived in a single consignment 
on April 21, 2003. Because the animals had been housed near 
each another before and during transport to the United States, 
it was impossible to determine at what point each of the differ-
ent types of animals might have become infected and which, if 
any, might have harbored the virus at their time of capture. 
 To determine the precise geographic origin of the infected 
animals and to assess whether one or more of the three impli-
cated species might harbor MPXV in nature, we traveled to 
the area in which the animals were originally trapped and 
collected additional specimens (from the same time of year), 
which could then be tested for MPXV. Furthermore, we exam-
ined residents of nearby communities for serologic evidence of 
orthopoxvirus (OPXV) exposure to determine to what extent 
persons living near these animals might be exposed to the 
virus. The findings of these investigations are detailed below. 
 METHODS 
 Animal collections.  The origin of the MPXV-infected 
animals imported into the United States on April 21, 2003, was 
traced to a single facility in Accra, Ghana. A description of 
husbandry practices at the facility was undertaken by officials 
from the Ghanaian Wildlife Division in cooperation with the 
owner, focusing on animal housing, turnover, shipping, and 
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other practices that could have influenced virus transmission 
among captive animals. 
 Two localities outside Accra were identified by the facility 
owner as being the areas from which the original animals from 
the April 2003 shipment had been collected. One site (5.98125N, 
0.58489E) was near the town of Sogakofe, in the Volta region 
and the other site (5.78562N, 1.01410W) was near the city of 
Oda in the Eastern region. In March–April, 2004, animals rep-
resenting several of the species contained in the 2003 consign-
ment and others commonly found in the two source areas were 
collected and evaluated for the presence of MPXV and for 
serologic evidence of prior or current infection. 
 The collection and processing of animals followed  Methods 
for Trapping and Sampling Small Mammals for Virologic Testing 
published by the Centers for Disease Control and Prevention 
(CDC). Live animals were handled according to guidelines 
and recommendations of the CDC Institutional Animal Care 
and Use Committee and as outlined in The Institutional 
Animal Care and Use Committee protocol  Field Collections 
in Zoonoses Investigations . Small rodents were either trapped 
live by using live traps (H. B. Sherman Traps, Tallahassee, FL) 
and locally produced live traps or were captured live by hand. 
Gross pathologic examinations were followed by a complete 
necropsy in which blood, heart, liver, kidney, lung, spleen, and 
skin samples were collected and immediately frozen at −20°C 
before being transferred to dry ice coolers. Specimens were 
split, with half remaining at the Noguchi Memorial Institute 
for Medical Research in Accra and half sent to CDC labora-
tories in Atlanta. 
 The CDC laboratories in Atlanta evaluated tissue spec-
imens for evidence of OPXV and MPXV (by using a poly-
merase chain reaction [PCR] and virus culture) and assayed 
blood specimens for antibodies (by using an enzyme-linked 
immunosorbent assay [ELISA]). 
 Serosurvey.  Residents living in villages near the two original 
trapping sites were contacted by Ghanaian Ministry of Health 
officials and CDC investigators and asked to participate in a 
research study to evaluate human exposure to OPXV species. 
Local Ministry of Health workers explained the purpose of 
the study and read the consent form to prospective enrollees, 
translating from English when necessary. Parental consent was 
obtained for persons less than 18 years of age. Adolescents 
(age = 11–17 years) and children (age = 7–10 years) were asked 
to provide their assent to participate in the study. 
 Persons who consented to participate were asked to provide 
basic demographic information (e.g., age, occupation) and to 
answer several questions pertaining to illness history, small-
pox vaccination status, and exposure to wildlife. In addition, 
one blood specimen was collected from each study participant. 
Blood for serologic testing was collected in standard marble-
top vacutainer™ tubes and stored refrigerated for not more 
than 48 hours before being centrifuged. Centrifugation and 
collection of serum was conducted at the Noguchi Memorial 
Institute for Medical Research. Serum specimens were divided 
and frozen; one aliquot was kept at the Ministry of Health 
laboratories and one was sent to CDC for analysis of OPXV-
reactive IgG and IgM. 
 Persons who participated were compensated for their time 
and effort. The protocol for this study was reviewed and 
approved by institution review boards at the CDC in Atlanta 
(CDC protocol #4043) and at the Noguchi Memorial Institute 
for Medical Research in Accra. 
 Laboratory methods.  Detailed methods for preparation 
and analysis of tissues using real-time PCR are described 
elsewhere. 11 All processing of animal tissues was performed 
under BioSafety Level 3 conditions. Solid tissues (pooled or 
individual) were placed in disposable dounce homogenizers 
(Kendall Large Tissue Grinders; Kendall Company catalog no. 
3500SA; Tyco Healthcare, Mansfield, MA). One milliliter of 
phosphate-buffered saline was added to each measured tissue 
sample before grinding to enable creation of slurries. Genomic 
DNA was prepared from an aliquot of each slurry (kit catalog 
no. 732-6340; Bio-Rad, Hercules, CA). Remaining tissue slur-
ries were stored for future virus isolation (see below). 
 Nucleic acid samples prepared from pooled tissues were 
tested by real-time PCR for OPXV DNA before testing indi-
vidual tissues. The primer/probe sequences were selected from 
the DNA polymerase gene (E9L; GenBank accession no. 
L22579) with Primer Express version 1.5 (Applied Biosystems, 
Foster City, CA). These sequences included OPX forward 
primer (5′-TCA AAT ATT GAT CGT CCA ACG A-3′), OPX 
reverse primer (5′-TGG ATG AAT TTC TCA ATA TTA GTT 
GG-3′), and OPX probe (5′FAM-TAA CAT CCG TCT GGA 
GAT ATC CCG TTA GA-BHQ1-3′). Primers and probe 
were synthesized in the Biotechnology Core Facility (CDC) 
by using standard phosphoramidite chemistry. Each reaction 
(25 μL) contained 5 μL of template DNA, 0.5 μL of each 
primer, 0.5 μL probe added to the LightCycler FastStart DNA 
Master HybProbe (2.5 μL vial 1 [DNA polymerase], 3 μL vial 2 
[25 mM MgCl 2 ], and 10.25 μL vial 3 [water]; Roche, Indianapolis, 
IN) and TaqMan Exogenous Internal Positive Control (2.5 μL 
10× Internal Positive Control Mix and 0.25 μL 50× Internal 
Positive Control DNA; Applied Biosystems). Thermal cycling 
conditions for the ABI7900 apparatus (Applied Biosystems) 
were one cycle at 95°C for 10 minutes and 45 cycles at 95°C 
for 15 seconds and 60°C for 1 minute. The PCR amplification 
is based on fluorescent emission after annealing/elongation 
(60°C). 
 Each reaction in the real-time assay was performed in tripli-
cate, and the operator was blinded to the identity of the source 
DNA. Vaccinia virus Wyeth DNA (50 fg) was used as a posi-
tive control and six wells with water were used as negative 
controls. In all wells, the ABI TaqMan exogenous internal pos-
itive control DNA (Applied Biosystems) and primers/probe 
mixture was included to assay for PCR inhibition that may be 
caused by the sample. Any tissue pool showing a positive result 
in the assay was further analyzed at the level of individual 
tissue (i.e., samples of kidney, eyelid, tongue, brain, blood, 
heart, liver, gonad, lesion, oral swab, ocular swab, lymph node, 
feces, skin, and urine). Specimens from individual tissues that 
had positive results were also analyzed for MPXV-specific 
DNA signatures (targeting the B6R gene encoding an enve-
lope protein 12 ), and an aliquot of the sample slurry was used 
for virus isolation on cultured BSC-40 cells. Reproducibly 
positive samples were additionally analyzed for a secondary 
OPXV DNA sequence (14-kD fusion protein, A27L) by using 
the Artus Orthopox LC PCR kit (Qiagen, Valencia, CA). 13 
Tissue specimens for which positive results were not repro-
ducible were scored as equivocal; further analysis was not 
attempted on these specimens. A modified OPXV ELISA was 
used for animal screening. 11, 14 
 Human serum samples were assessed for IgG and IgM 
reactive with OPXV antigen in accordance with published 
methods. 14 Antibody positivity was measured and compared 
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with reference standards. Any reading that was three stan-
dard deviations above the mean of the negative controls was 
inferred to be positive. 
 Statistical analyses.  Epidemiologic and demographic 
variables and qualitative laboratory findings were analyzed 
by using parametric and nonparametric statistical tests. 
Nonparametric statistical tests were used when analyzing 
subsets of data that were not normally distributed. The 
Mantel-Haenszel common odds ratio (OR) and Fisher’s exact 
tests (two-tailed) were used for categorical variables, and the 
Student’s  t -test was used for comparison of means derived 
from continuous variables. A  P value < 0.050 was used to 
measure significance of associations. 
 RESULTS 
 Investigation of export facility.  Interviews with the U.S. 
importer and the licensed commercial Ghanaian exporter 
indicated that in March–April 2003 collections of multiple 
Ghanaian mammal species were made by local persons. These 
animals were subsequently shipped to the United States. 
The shipment included several rodent species including 
Gambian rats ( Cricetomys spp.), rope squirrels ( Funisciurus 
spp.), dormice ( Graphiurus spp.), sun squirrels ( Heliosciurus 
spp.), striped mice ( Lemiscomys barbarus ), and brush-tailed 
porcupines ( Atherurus africanus ). These collections were 
made gradually over a period of a few weeks. While awaiting 
shipment, the pouched rats were stored together in concrete 
enclosures and the squirrels were housed in contiguous wire 
mesh cages with several individuals per cage. All animals 
were grouped with members of their own species. Most of 
the squirrels, and pouched rats were collected in a forest 
zone northwest of Accra ( Figure 1 ). The potential of a 
second collection site for at least one of the Genera collected 
( Cricetomys ) could not be ruled out by the Ghanaian exporter. 
The dormice were collected from a lowland scrub vegetation 
area near the Volta River northeast of Accra. These two sites 
are separated by approximately 200 miles ( Figure 1 ). 
 The animal shipments were packed into multi-tiered wooden 
crates with wire-lined compartments. Members of each of the 
smaller species ( Lemniscomys and  Graphiurus ) were shipped 
with approximately 25 animals per compartment. The exporter 
reported seeing nothing unusual as far as overt disease in the 
animals before shipment, nor were any unusual animal die-
offs seen at his facility before shipment. The shipment was sent 
as freight aboard a commercial airline and entered the United 
States through Dallas, Texas. 
 Animals collected during the investigation.  To determine 
which species of interest might be capable of harboring MPXV 
in nature, members of the Ghanaian Division of Wildlife 
Services, CDC, the U.S. Department of Agriculture, and local 
trappers collected 204 animals over nine nights during March 
24–April 2, 2004. Approximately 28% (57 animals) were 
collected in the Eastern region and the remaining from the 
Volta region ( Table 1 ). All were apparently healthy adult or 
sub-adult animals. 
 Among 182 animals for which serologic analysis was 
performed, only 2 (one a  Cricetomys sp. and the other a 
 Funisciurus sp.) had detectable levels of antibodies against 
OPXV at the highest reciprocal serum dilution of 400 ( Table 1 ). 
One additional  Funisciurus sp. and one Gambian Sun squirrel 
( Heliosciurus gambianus ) had low levels of antibodies against 
OPXV . Moderate levels of antibodies against OPXV were 
detected in two  Graphiurus spp. (at a reciprocal dilution of 
200), and seven others had low levels of antibodies. 
 Using the molecular screening algorithm outlined above, we 
found that 6 of 97  Graphiurus , 2 of 38  Cricetomys , and 1 of 
1  Xerus showed evidence of OPXV DNA signatures in har-
vested tissue specimens ( Table 2 ). An additional 26 other ani-
mals, 13  Graphiurus , 9  Cricetomys , 3  Funiciurus , and 1  Xerus , 
showed equivocal results. 
 Tissues from the nine animals that showed positive results 
by real-time PCR specific for OPXV (generic) polymerase 
(E9L) DNA signatures were also assayed for a secondary 
OPXV DNA target (14-kD fusion protein). Three of the nine 
animals were also positive for this secondary OPXV ( Xerus 
289,  Graphiurus 389, and  Graphiurus 431) ( Table 2 ). All ani-
mals were subsequently screened for MPXV-specific signa-
tures by using a real-time PCR designed to detect sequences 
corresponding to the MPXV envelope protein (B6R). The 
MPXV-specific DNA signals were not reproducibly detected 
in any of the specimens. However, the MPXV-specific assay 
is slightly less sensitive than the OPXV generic A27L assay 
(10 genomes versus 4 genomes, respectively). 12, 13 A cytopathic 
effect caused by OPXV was not observed in virus cultures 
prepared from the tissues of any animals, nor was culturable 
virus obtained after serial passage. (In our hands, virus culture 
is typically 10–100-fold less sensitive than the most sensitive 
real-time PCR in detecting OPXV in clinical specimens.) 
 One  Graphiurus spp. (animal number 431) had a low level 
of antibodies against OPXV in its serum and OPXV DNA 
signatures in its spleen. Two  Funisciurus spp. with antibodies 
 Figure 1.  Map of Ghana, showing the two survey locations. 
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against OPXV had equivocal OPXV DNA findings in pooled 
organ specimens in the PCR screening. 
 Human serosurvey.  To investigate whether persons working 
closely with sylvan animals and humans living near animal 
trapping sites might be at enhanced risk for exposure to OPXVs, 
we conducted a serosurvey among residents of several villages 
within walking distance of where the animals implicated in the 
U.S. outbreak had been originally collected. For purposes of this 
study, these villages will be referred to as villages A/B (Eastern 
region) and Village C (Volta region). In all, 65 residents of 
village C (approximately 92% of the total village population), 
100 residents of villages A/B (approximately 33% and 85% of 
the total village populations, respectively), and 7 persons who 
were directly involved in the exotic animal trade consented 
to participate in the serosurvey ( Table 3 ). The sex distribution 
and occupations of study participants were similar between the 
Eastern Region and Volta region survey sites, but the proportion 
of persons greater than 23 years of age enrolled from the Volta 
region was higher than that from the Eastern region. 
 Most village residents reported that they entered the forest 
at least once a week (98% and 95% for villages A/B and C, 
respectively), whereas five of six of those actively engaged 
in the animal trade reported only going into the forest on a 
monthly basis. Cultivation and firewood collection were cited 
most frequently as the principal reason for participants going 
into forested areas (n = 76 [71%] and n = 28 [26%], respec-
tively), among those 107 participants who provided a response 
to the question. A higher proportion of men than women cited 
cultivation as the reason for entering the forest (67% versus 
33%, respectively); this bias was of similar proportion in the 
Eastern and Volta regions. Other reasons cited for forest entry 
were animal trapping related activities (n = 2) and accompa-
nying adults (n = 1). 
 All enrolled study participants provided blood for quantifi-
cation of IgG and IgM against OPXV. Serologic tests used in 
this study do not detect specific antibodies against MPXV but 
do detect antibodies broadly cross-reactive against antigens 
from multiple OPXVs, including MPXV and vaccinia virus 
(the live virus component of the smallpox vaccine). 
 None of the study participants had positive results for IgM 
against OPXV, which suggested that none had been exposed 
to an OPXV (for which they had been previously immuno-
logically negative) within the prior two months. 14 However, 91 
(53%) study participants had detectable levels of IgG against 
OPXV ( Figure 2A ). A higher proportion of those greater than 
23 years of age, as opposed to those younger, had detectable 
IgG against OPXV (n = 51 [81%] versus n = 40 [37%], respec-
tively). This finding is consistent with the fact that many of the 
older persons in this study would likely have had the opportu-
nity to have received smallpox vaccination (or may even have 
been exposed to variola virus before smallpox eradication). 
Smallpox vaccination typically results in life-long persistence 
of IgG against OPXV. The 24 study participants who reported 
having received smallpox vaccination at some point in life all 
had detectable IgG against OPXV and visible vaccination 
scars; all were greater than 23 years of age. 
 The proportion of adults (greater than 23 years of age) with 
positive findings for IgG against OPXV was relatively similar 
 Table 2 
 Characteristics of animals that had evidence of infection with orthopoxvirus, Ghana * 
Genus and animal Sex Age Tissue E9L PCR A27L PCR Orthopoxvirus ELISA titer 1:50
 Graphiurus 326 M Adult Pool Positive Negative Negative
 Graphiurus 369 M Adult Pool Positive Negative Negative
 Graphiurus 389 F Adult Spleen Positive Positive Negative
Liver Positive Negative Negative
 Graphiurus 404 M Adult Lung Positive Negative Negative
 Graphiurus 431 F Adult Spleen Positive Positive Positive
 Graphiurus 485 F Adult Skin Positive ND Negative
Pool Positive Negative Negative
 Cricetomys 459 F Sub-adult Spleen Positive Negative Negative
 Cricetomys 460 F Sub-adult Spleen Positive Negative Negative
 Xerus 289 F Adult Spleen Positive Positive Negative
 * PCR = polymerase chain reaction; ELISA = enzyme-linked immunosorbent assay; ND = not determined. 
 Table 1 
 Results of laboratory testing to detect presence of orthopoxvirus DNA and antibody against orthopoxvirus from tissue and blood specimens of 
rodents collected in two regions of Ghana * 
Genus No. Region
Orthopoxvirus DNA detection by real-time PCR † Orthopoxvirus antibody ELISA endpoint titers
Positive ‡ Equivocal § Negative % Positive 1:50 1:100 1:200 1:400 No. tested
 Graphiurus 100 Volta 6 13 78 6 7 ¶ 0 2 0 90
 Cricetomys 40 Eastern 2 9 27 5 0 0 0 1 38
 Lemniscomys 24 Volta 0 0 24 0 0 0 0 0 20
 Tatera 9 Volta 0 0 9 0 0 0 0 0 9
 Funiscirus 9 Eastern 0 3 6 0 1 0 0 1 5
 Mus 8 Volta 0 0 8 0 0 0 0 0 8
 Heliosciurus 7 Eastern 0 0 4 0 1 0 0 0 7
 Arvicanthis 6 Volta 0 1 6 0 0 0 0 0 4
 Xerus 1 Eastern 1 0 0 100 0 0 0 0 1
 *  PCR = polymerase chain reaction; ELISA = enzyme-linked immunosorbent assay. 
 † The orthopoxvirus DNA detection threshold for the orthopoxvirus generic E9L polymerase real-time PCR assay is ≥ 2 fg of purified vaccinia DNA. 
 ‡  Result replicated in independent assay; represents finding from liver, spleen, skin, and/or pooled organ specimens. Details are shown in  Table 2 . 
 §  < 3 of 3 replicated positive for pooled organ specimen. 
 ¶ Female dormice were significantly more likely to have Opx-reactive titers at 1:50 than males ( P = 0.030, by Fisher’s exact test, 2-sided). 
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in study participants from the Eastern and Volta regions (87% 
and 77%, respectively). However, among persons ≤ 23 years 
of age, there was a significantly greater probability of a posi-
tive finding for IgG against OPXV among those living in the 
Eastern region (OR = 4.05, 95% confidence interval [CI] = 
1.50–11.03) ( Table 4 and  Figure 2B ). Those persons engaged 
in the exotic animal trade were not more likely to have IgG 
against OPXV than village residents (independent of age). 
Sex or reported frequency of visits into forested areas were 
not individually associated with IgG against OPXV. 
 The principal reason persons cited for going into the for-
est was associated with status of IgG against OPXV, but in 
an age-delimited fashion. It has been estimated that half of 
boys and girls 10–14 years of age in Ghana are substantively 
engaged in farming and domestic work, which is double the 
proportion of those 7–9 years of age involved in these activi-
ties. 15 Among study participants greater than nine years of age 
(persons anticipated to have significant levels of engagement 
in the activity cited) with no history of smallpox vaccination, 
cultivation, rather than firewood collection, was found to be 
significantly associated with IgG against OPXV (OR = 3.24, 
95% CI = 1.00–10.47) ( Table 4 ). 
 Evaluation of absolute levels of IgG against OPX in the study 
population showed that in persons ≤ 23 years of age, levels 
 Table 3 
 Characteristics of persons from the Eastern and Volta regions of Ghana who participated in the serosurvey 
Characteristic
Category No. (%)
Total (%)Eastern region resident Volta region resident Exotic animal professional
Total 100 (100) 65 (100) 7 (100) 172 (100)
Sex
 M 54 (54) 37 (57) 6 (86) 97 (56)
 F 46 (46) 28 (43) 1 (14) 75 (44)
Age, years * 
 ≤ 23 70 (70) 35 (54) 4 (57) 109 (64)
 > 23 30 (30) 30 (46) 3 (43) 63 (36)
Prior smallpox vaccination † 
 Yes 11 (11) 12 (19) 1 (14) 24 (14)
 No 89 (89) 52 (81) 6 (86) 147 (86)
Occupation
 Exotic animal trader – – 7 (100) 7 (4)
 Farmer 30 (30) 30 (46) – 60 (35)
 Commercial 1 (1) – – 1 (1)
 Child/student 69 (69) 35 (54) – 104 (60)
Forest visits ‡ 
 At least once a week 95 (97.9) 61 (95.3) 1 (14.3) 157 (93.5)
 At least once a month 2 (2.1) 3 (4.7) 6 (85.7) 11 (6.5)
 *  Routine smallpox vaccinations in Africa ceased in 1982. Persons less than 24 years of age at time of enrollment in this study were not expected to have had the opportunity for childhood vac-
cination to protect against smallpox. 
 † Vaccination status is based on self-reporting. Vaccination scars were noted in 22 (92%) of 24 persons who provided a self-report of smallpox vaccination; one person from the Volta region with 
evidence suggestive of a vaccination scar denied having been vaccinated. This person was not included in either category. 
 ‡  Four persons enrolled in the study did not provide information pertaining to frequency of forest visits. 
 Figure 2.  Levels of serum IgG against orthopoxvirus (OPXV) (OD-COV) among study participants in Ghana, by age and region.  A , Scatterplot 
depicting OPXV IgG levels by age (years) across the study population. Blue = Easter region; cyan = Volta region; red = persons engaged in exotic 
animal trade.  B , Histograms showing the distribution of OD-COV values among persons ≤ 23 years of age, stratified by region, including persons 
≤ 23 years of age engaged in exotic animal trade. 
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were substantially below that which would be anticipated in 
persons with recent acute infection with OPXV ( Figure 3 ). To 
assess whether the relatively low ELISA optical density values 
observed in positive for IgG against OPXV across the study 
population were greater than would be expected from a known 
OPXV-negative population, the mean OPXV IgG level among 
IgG-positive persons ≥ 23 years of age from Ghana (the group 
with the lowest serum level of IgG against OPXV [OD-COV], 
n = 40) was compared with that of specimens obtained from 
persons not vaccinated against smallpox in the United States 
(persons ruled out for MPXV infection in 2003 by clinical, epi-
demiologic, and laboratory criteria, n = 74). 16 Although sub-
stantially lower than the mean OD-COV for persons acutely 
infected with MPXV and persons one year post-infection, the 
mean OD-COV for IgG-positive Ghanaians ≤ 23 years of age 
(OD-COV = 0.17) was significantly higher than that for OPXV-
negative persons in the United States (OD-COV = −0.05;  P < 
0.001 by two-sided Student’s  t -test, degrees of freedom = 41). 
 Although overall levels of IgG against OPXV among IgG-
positive persons in this study were low relative to what is typi-
cally observed within one year of acute OPXV infection, six 
persons in this study showed highly elevated levels of IgG 
against OPXV (defined here as OD-COV > 2 standard devia-
tions above the mean of the IgG-positive population in the 
study). All of these persons were greater than 23 years of age 
and described themselves as farmers. Five were from the Volta 
region; they reported having received smallpox vaccinations. 
One was from the Eastern region; this person did not report 
receiving a smallpox vaccination and had no evidence of a vac-
cine-associated scar. 
 DISCUSSION 
 Somewhat contrary to expectations, our results did not 
implicate a single species of animal as being the sylvan source 
of MPXV for the U.S. outbreak. We found evidence suggestive 
of intermittent exposure to OPXVs among various species 
across a broad geographic span. Species of animal showing 
evidence of OPXV exposure (i.e.,  Cricetomys spp.,  Graphiurus 
spp.,  Funiscuris spp.,  Xerus spp.) mirrored those implicated 
in the U.S. outbreak, 11 with the exception of the  Xerus spp., 
which had not previously been associated with OPXV expo-
sure. It should be emphasized that our study was not intended 
to constitute a comprehensive survey of the sylvan fauna of 
Ghana for evidence of OPXV infection. Only rodent spe-
cies were evaluated. Species implicated in the U.S. outbreak 
were preferentially collected. Many of the species were sam-
pled below the threshold needed to determine whether their 
OPXV nucleic acid and seroprevalence rates were compara-
ble to those observed for  Graphiurus spp., the most well sam-
pled species (for which nucleic acid and antibody prevalence 
rates of 6.2% and 10%, respectively, were observed). 
 If we assume that rodents, like humans, will sustain life-long 
detectable OPXV antibody titers after infection, the relatively 
 Figure 3.  Box plots of levels of serum IgG against orthopoxvirus 
(OPXV) (OD-COV) for  A , non–smallpox-vaccinated persons who 
were not infected with monkeypox virus (MPXV) infection by clini-
cal, epidemiologic, and laboratory criteria during the MPX outbreak 
in United States in 2003 (n = 74);  B , persons positive for IgG against 
OPXV ≤ 23 years of age in this study (n = 40);  C , persons confirmed 
as having MPXV infection during the U.S. outbreak approximately 
one year post-illness onset (n = 14); and  D , persons confirmed as hav-
ing MPXV infection during the U.S. outbreak with acute-phase illness 
(n = 15). 16 This figure appears in color at  www.ajtmh.org . 
 Table 4 
 Characteristics associated with IgG against orthopoxvirus among study participants * 
Characteristic
Orthopoxvirus ELISA
OR (95% CI)No. (%) positive No. (%) negative
≤ 23 years of age † 
 Eastern 32 (84.2) 38 (56.7) 4.07 (1.50–11.03)
 Volta 6 (15.8) 29 (43.3) –
> 23 years of age
 Eastern 26 (53.1) 4 (36.4) 1.98 (0.51–7.63)
 Volta 23 (46.9) 7 (63.6) –
Professional animal worker
 ≤ 23 years of age 2 (50) 2 (66.7) –
 > 23 years of age 2 (50) 1 (33.3) –
Primary reason for forest visits†
 Cultivation 31 (86.1) 23 (65.7) 3.24 (1.00–10.47)
 Firewood 5 (13.9) 12 (34.3) –
 * ELISA = enzyme-linked immunosorbent assay; OR = odds ratio; CI = confidence interval. 
 † Among persons > 9 years of age with no history of smallpox vaccination. 
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low seroprevalence rates observed for two of well sampled 
species of interest,  Graphiurus spp. and  Cricetomys spp. (2.6% 
and 10%, respectively), might indicate that these species are 
unlikely to serve as natural sylvan reservoirs for OPXVs. 
Members of the genus  Funisciurus , which showed a seroprev-
alence of 40%, might be good candidates. The only isolation of 
MPXV from an animal in the wild came from a  Furnisciurus 
anerythrus , 5 further indicating the relevance of this species as 
a putative maintenance source of the virus in nature. However, 
studies of other, better-characterized, rodent-borne zoonotic 
viruses have documented similarly low point seroprevalence 
rates. 17 Additionally, ecologic investigations of OPXVs from 
Europe performed in the United Kingdom, which investi-
gated the influence of cowpoxvirus infection on population 
cycles in the reservoir host (the field vole  Microtus agrestis ), 
have shown that population seroprevalence rates can vary 
temporally, thus limiting the informational value of single 
cross-sectional measurements to implicate, or rule out, virus 
maintenance hosts. 18 In one such study, 19 sharp decreases in 
seroprevalence were observed in bank vole populations that 
had experienced recent demographic crashes. The investiga-
tors noted that in some instances population seroprevalence 
decreased to undetectable levels after approximately two-fold 
decreases in density during the period six months prior, and 
conversely, reached as high as approximately 90% in the post-
rebound period (in delayed density-dependent fashion, with a 
lag occurring between population rebound and increased sero-
prevalence). Therefore, understanding the interplay between 
MPXV and the population dynamics of various candidate res-
ervoir species will be crucial to arriving at an accurate inter-
pretation of OPXV serologic and virologic findings. 
 Animal infection experiments that illuminate features of 
virus transmission dynamics and pathobiology in various can-
didate reservoir species can also be helpful in identifying the 
reservoir host, and differentiating it from other species that are 
merely permissive of virus replication. The interpretation of 
human serologic findings is similarly nuanced. Also, contrary 
to expectations, the results of our study did not show enhanced 
risk of OPXV exposure among persons directly involved in the 
exotic animal trade. Instead, we observed IgG against OPXV 
among a large proportion of those persons living in rural com-
munities near the original animal trapping sites, albeit no 
persons had serologic evidence suggesting recent infection. 
Smallpox vaccination continued in Africa until 1980. Therefore, 
a substantial proportion of persons greater than 23 years of age 
at the time that this study was performed would be anticipated 
to retain cross-reactive antibodies because of vaccination. The 
presence of antibodies against OPXV in persons born after 
cessation of vaccination is of somewhat greater interest. In this 
study, 36% of young non-vaccinated persons had IgG against 
OPXV. Within this group, mean values for absolute IgG (0.17, 
95% CI = 0.12–0.22; derived from a single-dilution ELISA OD 
values) decreased between those observed for OPXV-negative 
persons (–0.05, 95% CI = –0.04 to –0.06) and those anticipated 
for persons one year after having clinically defined MPXV 
infection (0.80, 95% CI = 0.93–1.25) ( Figure 3 ). 
 These comparison groups (OPXV-negative persons and per-
sons with clinically defined MPXV infection) are derived from 
investigations performed during the U.S. MPX outbreak. 14, 20 
The constituent population for this study is different in many 
ways from that that found in the United States, but in theory 
members of both groups, those exposed to MPXV-infected 
animals in the United States and Ghanaians living near the 
animal trapping sites, would have had opportunities for expo-
sure to the same strain of MPXV. The question of whether the 
intermediate levels of seropositivity observed in many young 
or otherwise unvaccinated persons in this study might be a 
consequence of asymptomatic or sub-clinical infections with 
this strain of MPXV is worthy of consideration. Asymptomatic 
MPXV infections in members of young age groups have been 
previously hypothesized, 21 and three persons affected dur-
ing the U.S. outbreak are presumed to have had sub-clinical 
MPXV infections. 22 However, all three of these persons had 
had prior smallpox vaccination and each had a robust IgG 
titer against OPXV. 
 Another possibility to account for intermediate levels of 
seropositivity is that perhaps beginning at a young age, per-
sons living in the areas surveyed may be exposed to other, 
as yet uncharacterized, OPXVs that are non-pathogenic in 
humans. Demonstration of this phenomenon emerged in the 
1970s when Baxby and others 23 demonstrated that young cam-
els, which were fully susceptible to infection with camelpox 
virus, could not be productively infected with variola virus. 
However, exposure to variola virus by scarification resulted 
in production of intermediate-level titers of antibodies against 
OPXV in these animals, 23 which were sufficient to provide 
protection against subsequent challenge with camelpox virus. 
Taterapox virus is one example of an OPXV that has been 
identified in west Africa that has an unknown pathogenic 
capacity in humans. 24 
 In general, a broad comparison between the age-specific 
seroprevalences seen in this study from Ghana versus one 
performed in an MPXV-endemic setting in the Democratic 
Republic of the Congo in 1981 21 showed similar progressive 
increases in age-specific seroprevalence through successive 
older age classes, but the overall proportion of seropositive 
persons at each age class was considerably elevated in this 
study as opposed to the former study. Similar to the study 
in the Democratic Republic of the Congo, children in this 
study from communities surrounded by dense forest (Eastern 
region) had a significantly higher probability of being sero-
positive than did children from villages surrounded by mosaic 
forest-savannah habitat. The habitats in these different areas 
tend to support varied abundances of several common animal 
species, including those species of rodent implicated in the 
MPXV importation event to the United States;  Funisciurus 
spp. and  Cricetomys spp. were more commonly trapped in the 
Eastern locations and  Graphiurus sp. was more commonly 
trapped in the Volta Region. The potential for differing inten-
sities of human exposure to rodent species harboring MPXV 
exists between the two areas, but has yet to be demonstrated. 
Cultivating crops in forested areas was also significantly asso-
ciated with the presence of antibodies against OPXV (in non-
vaccinated persons greater than nine years of age). This finding 
could also be associated with enhanced opportunities for con-
tact with sylvan rodents (crop pests). Alternatively, cultivation 
activities could merely signal more frequent and longer dura-
tions of time spent by persons in a forested habitat. 
 The lack of an appropriate urban Ghanaian population 
sample against which to compare human serologic findings 
and risk factor data limits our ability to investigate absolute 
risks for OPXV exposure attributable to living in rural com-
munities. Also, the cross-sectional nature of our study pre-
cluded our ability to fully explore the possibility that some 
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OPXV-seropositive persons may have had sub-clinical OPXV 
infections, a question better addressed in a prospective investi-
gation. Other limitations preventing broader interpretation of 
our study findings include the fact that not all questions were 
answered by all participants, and that our survey investigation 
tool was insufficient to capture reliable (non-biased) individ-
ual responses to questions about animal exposure. 
 In summary, the accumulated findings from this study lead us 
to conclude that no one species of animal and neither collection 
site could be strongly implicated, nor dismissed, as being the 
source for the MPXV imported into the United States in 2003. 
Rather, our results are suggestive of geographically widespread 
exposure to OPX among rodents found at both sites, near both 
communities surveyed, leading us to postulate that persons liv-
ing in these communities may have enduring, but potentially 
low-intensity or indirect, exposure to OPXV- infected animals 
resulting in sub-clinical (i.e., asymptomatic) infection concomi-
tant with seroconversion. Possibilities for exposure are likely to 
begin at a young age, with additional risks present for children 
living in heavily forested areas. The presence of substantial 
clinical illness associated with MPXV infection among per-
sons in the United States might be explained by the virus hav-
ing passed through an amplification host, namely prairie dogs. 
Contact with MPXV-infected prairie dogs was identified in 
each instance of human infection, whereas no persons coming 
into contact with infected African rodents became infected. 22 
We cannot discount the possibility that other uncharacterized 
OPXVs are also circulating in southern Ghana. This possibility 
should also be thoroughly explored. 
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